Blockade of TNFR with TNFRII.Ig, anti-TNF antibodies, or via anti-LTα treatment reduced TU-HEV areas specifically in Treg-depleted fibrosarcomas, while LTbR-Ig had no effect (108). Here, TNF is linked to fibrosarcoma.